Cargando…
Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among women in United Sates and the leading cause of death from gynecological malignancies. While most OvCa patients initially respond to surgical debulking and chemotherapy, 75% of patients later succumb to the disease....
Autores principales: | Giri, Shailendra, Karakoti, Ajay, Graham, Rondell P., Maguire, Jacie L., Reilly, Christopher M., Seal, Sudipta, Rattan, Ramandeep, Shridhar, Viji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561344/ https://www.ncbi.nlm.nih.gov/pubmed/23382918 http://dx.doi.org/10.1371/journal.pone.0054578 |
Ejemplares similares
-
Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer
por: Giri, Shailendra, et al.
Publicado: (2014) -
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
por: Hijaz, Miriana, et al.
Publicado: (2016) -
Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse
por: Zhou, Xiaohong, et al.
Publicado: (2011) -
Non-toxic retention of nanoceria in murine eyes
por: Cai, Xue, et al.
Publicado: (2016) -
Catalytic Nanoceria Are Preferentially Retained in the Rat Retina and Are Not Cytotoxic after Intravitreal Injection
por: Wong, Lily L., et al.
Publicado: (2013)